Core Viewpoint - Tianyu Biotechnology Co., Ltd. is expected to report a significant net loss for the fiscal year 2025, with projected losses ranging from 125 million to 85 million yuan, indicating a challenging financial outlook for the company [2][4]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. - The company anticipates a net profit attributable to shareholders of the parent company to be between -125 million yuan and -85 million yuan for 2025 [4]. - The expected net profit after deducting non-recurring gains and losses is projected to be between -165 million yuan and -120 million yuan [4]. Group 2: Previous Year Performance - In the same period last year, the total profit was -87.16 million yuan, with a net profit attributable to shareholders of the parent company at -107.36 million yuan [6]. - The net profit after deducting non-recurring gains and losses was -113.14 million yuan [6]. - The earnings per share for the previous year were -0.3700 yuan [7]. Group 3: Reasons for Expected Loss - The expected loss is primarily due to the performance of the pig farming and ecological environment businesses [8]. - The national pig sales prices showed a "high first, low later" trend, with a significant decline in prices during the second half of the year, leading to reduced revenue despite a 22.92% increase in sales volume [8]. - The company has been reducing its ecological environment business, with some project settlements not meeting expectations, resulting in continued losses in this segment [8]. Group 4: Non-Operating Gains and Accounting Impact - The company renegotiated a lease for a pig farm, resulting in a significant decrease in annual rent, which is expected to generate a one-time gain of approximately 24.10 million yuan [9]. - This gain is not sustainable and does not significantly impact the overall expected loss [9]. - There are no other significant factors affecting the performance forecast [9].